Page last updated: 2024-10-24

celecoxib and Leukemia

celecoxib has been researched along with Leukemia in 5 studies

Leukemia: A progressive, malignant disease of the blood-forming organs, characterized by distorted proliferation and development of leukocytes and their precursors in the blood and bone marrow. Leukemias were originally termed acute or chronic based on life expectancy but now are classified according to cellular maturity. Acute leukemias consist of predominately immature cells; chronic leukemias are composed of more mature cells. (From The Merck Manual, 2006)

Research Excerpts

ExcerptRelevanceReference
"This study was aimed to investigate the influence and significance of celecoxib (specific inhibitor of cyclooxygenase-2) on mRNA expressions of vascular endothelial growth factor (VEGF), basic fibroblast growth factor (b-FGF), transforming growth factor β (TGF-β) in acute leukemia cells."7.78[Effects of COX-2 inhibitor celecoxib on expressions of VEGF, b-FGF and TGF-β mRNA in acute leukemia cells]. ( Ruan, LH; Zhang, YF; Zhao, XQ, 2012)
"This study was aimed to investigate the influence and significance of celecoxib (specific inhibitor of cyclooxygenase-2) on mRNA expressions of vascular endothelial growth factor (VEGF), basic fibroblast growth factor (b-FGF), transforming growth factor β (TGF-β) in acute leukemia cells."3.78[Effects of COX-2 inhibitor celecoxib on expressions of VEGF, b-FGF and TGF-β mRNA in acute leukemia cells]. ( Ruan, LH; Zhang, YF; Zhao, XQ, 2012)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sobolewski, C1
Rhim, J1
Legrand, N1
Muller, F1
Cerella, C1
Mack, F1
Chateauvieux, S1
Kim, JG1
Yoon, AY1
Kim, KW1
Dicato, M1
Diederich, M1
Lu, Y1
Liu, XF1
Liu, TR1
Fan, RF1
Xu, YC1
Zhang, XZ1
Liu, LL1
Zhang, YF1
Ruan, LH1
Zhao, XQ1
Li, RJ1
Gong, FJ1
Zhang, GS1
Kempen, EC1
Yang, P1
Felix, E1
Madden, T1
Newman, RA1

Other Studies

5 other studies available for celecoxib and Leukemia

ArticleYear
2,5-Dimethyl-celecoxib inhibits cell cycle progression and induces apoptosis in human leukemia cells.
    The Journal of pharmacology and experimental therapeutics, 2015, Volume: 355, Issue:2

    Topics: Animals; Antineoplastic Agents; Apoptosis; Calcium; Celecoxib; Cell Cycle; Cell Line, Tumor; Cell Pr

2015
Celecoxib exerts antitumor effects in HL-60 acute leukemia cells and inhibits autophagy by affecting lysosome function.
    Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 2016, Volume: 84

    Topics: Antineoplastic Agents; Apoptosis; Autophagy; Celecoxib; Cell Proliferation; Chloroquine; HL-60 Cells

2016
[Effects of COX-2 inhibitor celecoxib on expressions of VEGF, b-FGF and TGF-β mRNA in acute leukemia cells].
    Zhongguo shi yan xue ye xue za zhi, 2012, Volume: 20, Issue:5

    Topics: Adult; Celecoxib; Cyclooxygenase 2 Inhibitors; Female; Fibroblast Growth Factor 2; Humans; Leukemia;

2012
[Cytotoxic activities of Celecoxib on leukemic cells and the synergistic effects of Celecoxib with Imatinib thereupon].
    Zhonghua yi xue za zhi, 2006, May-30, Volume: 86, Issue:20

    Topics: Apoptosis; Benzamides; Celecoxib; Cell Proliferation; Cyclin-Dependent Kinase Inhibitor p27; Drug Sy

2006
Simultaneous quantification of arachidonic acid metabolites in cultured tumor cells using high-performance liquid chromatography/electrospray ionization tandem mass spectrometry.
    Analytical biochemistry, 2001, Oct-15, Volume: 297, Issue:2

    Topics: 12-Hydroxy-5,8,10,14-eicosatetraenoic Acid; Animals; Arachidonic Acid; Celecoxib; Chromatography, Hi

2001